Literature DB >> 26129900

Dalitong granule combined with electroacupuncture in the treatment of functional dyspepsia: A randomized controlled trial.

Chao-xian Zhang1, Li-ke Guo2.   

Abstract

OBJECTIVE: To explore clinical short and long-term effect of combining dalitong granule (DG) and electroacupuncture group (EA) in the treatment of functional dyspepsia.
METHODS: Totally 640 patients with confirmed functional dyspepsia were randomly divided into 4 groups using a randomized digital table: the DG group, the EA group, the combined group and the control group, 160 cases in each group. The DG group was treated with 6 g DG 3 times daily; the EA group was treated with puncture of points Zusanli (ST36), Zhongwan (CV12), Neiguan (PC6), Taichong (LR3) and Gongsun (SP4) twice daily; the combined group with above-mentioned DG and EA; and the control group with 5 mg mosapride 3 times, 20 mg pantoprazole and 25 mg amitriptylines twice daily. The treatment course was 4 weeks for all groups. The symptom score, quality of life score by Short Form 36 Health Survey Questionnaires (SF-36), plasma motilin by radioimmunoassay, electrogastrographic frequencies by electrogastrogram (EGG) and gastric emptying by B-sonography were examined, and adverse reactions were observed before, at the end of treatment and 60 weeks post-treatment.
RESULTS: In the DG group 1 case dropped out for not taking medicine strictly and 1 case was lost to follow-up, while 1 case in the EA group and 2 cases in the combined therapy group were lost to follow-up. Compared with pre-treatment, quality of life score, plasma motilin, electrogastrographic frequencies and gastric emptying were all increased significantly, while symptom score was decreased significantly at the end of treatment in each group (P<0.01); in the combined group quality of life score, plasma motilin, electrogastrographic frequencies and gastric emptying were all significantly higher than those in the other groups, while symptom score was significantly lower than in the other groups (P<0.05). Compared with at the end of treatment, these indices changed insignificantly in the combined group and the EA group 60 weeks post-treatment (P>0.05), but the 4 increased indices were all decreased significantly, and symptom score was increased significantly in the DG and the control groups (P>0.05). The short and long-term total effective rates in the combined group were all significantly higher than those in the other treatment groups (P<0.05 or P<0.01). No serious adverse reaction occurred in the four groups.
CONCLUSION: Combined treatment of DG and EA could increase both plasma motilin and electrogastrographic frequencies, promote gastric emptying, alleviate the symptom of dyspepsia so as to increase quality of life, with better safety and long-term effect.

Entities:  

Keywords:  Chinese medicine; Dalitong Granule; clinical trial; electroacupuncture; electrogastrography; gastric emptying; plasma motilin; quality of life

Mesh:

Substances:

Year:  2015        PMID: 26129900     DOI: 10.1007/s11655-015-2175-5

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  15 in total

1.  [Effect of acupuncture on contents of beta-endorphin in the plasma and hypothalamus in rats with stress-induced gastric mucosal injury].

Authors:  Yan-jing Han; Wei-wei Dai; Lei Peng; Lei Zhou; Hui-fang Ma
Journal:  Zhen Ci Yan Jiu       Date:  2011-10

Review 2.  Functional dyspepsia.

Authors:  Jan Tack; Tatsuhiro Masaoka; Pieter Janssen
Journal:  Curr Opin Gastroenterol       Date:  2011-10       Impact factor: 3.287

3.  Psychometric properties of the Chinese version of the SF-36 in older adults with diabetes in Beijing, China.

Authors:  Jie Hu; Kenneth J Gruber; Kuei-Hsiang Hsueh
Journal:  Diabetes Res Clin Pract       Date:  2010-04-13       Impact factor: 5.602

4.  Proton-pump inhibitors for the treatment of functional dyspepsia.

Authors:  Hidekazu Suzuki; Sawako Okada; Toshifumi Hibi
Journal:  Therap Adv Gastroenterol       Date:  2011-07       Impact factor: 4.409

5.  Functional dyspepsia impairs quality of life in the adult population.

Authors:  P Aro; N J Talley; L Agréus; S-E Johansson; E Bolling-Sternevald; T Storskrubb; J Ronkainen
Journal:  Aliment Pharmacol Ther       Date:  2011-03-28       Impact factor: 8.171

6.  Prevalence of functional gastrointestinal disorders in Taiwan: questionnaire-based survey for adults based on the Rome III criteria.

Authors:  Fang-Yuan Chang; Po-Hon Chen; Tzee-Chung Wu; Wen-Harn Pan; Hsing-Yi Chang; Shin-Jiuan Wu; Nai-Hua Yeh; Ren-Bin Tang; Lite Wu; Frank E James
Journal:  Asia Pac J Clin Nutr       Date:  2012       Impact factor: 1.662

7.  Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study.

Authors:  Victoria P Y Tan; Tin K Cheung; Wai M Wong; Roberta Pang; Benjamin C Y Wong
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 8.  [Diagnosis and pathogenesis in functional dyspepsia].

Authors:  Ken Haruma; Hiroshi Imamura; Hiroaki Kusunoki; Noriaki Manabe; Jiro Hata
Journal:  Nihon Rinsho       Date:  2008-07

9.  Dyspepsia: Psychological factors in functional dyspepsia--keeping an open mind.

Authors:  Isobel Franks
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-07       Impact factor: 46.802

10.  [Experimental study on electroacupuncture for strengthening gastrointestinal motility in the rat with acute pancreatitis].

Authors:  Jie Li; Xiu-feng Shi; Ling-yun Zhou; Dong-bo Xue
Journal:  Zhongguo Zhen Jiu       Date:  2008-05
View more
  8 in total

1.  Electroacupuncture Stimulation of Language-Implicated Acupoint Tongli (HT 5) in Healthy Subjects: An fMRI Evaluation Study.

Authors:  Lin-Ling Li; Xiao-Wu Liu; Fang Wu; Dong-Chang Tong; Li-Ping Ye; Hong-Xing Tao; Peng Liu; Yun-Hai Qiu; Wan-Zhang Yang
Journal:  Chin J Integr Med       Date:  2017-12-11       Impact factor: 1.978

2.  Acupuncture for functional gastrointestinal disorders: A systematic review and meta-analysis.

Authors:  Xi-Yang Wang; Hao Wang; Yuan-Yuan Guan; Rong-Lin Cai; Guo-Ming Shen
Journal:  J Gastroenterol Hepatol       Date:  2021-08-18       Impact factor: 4.369

3.  Electroacupuncture treatment partly promotes the recovery time of postoperative ileus by activating the vagus nerve but not regulating local inflammation.

Authors:  Jun-Fan Fang; Jian-Qiao Fang; Xiao-Mei Shao; Jun-Ying Du; Yi Liang; Wen Wang; Zhe Liu
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

4.  Effect of Electroacupuncture on the NTS is modulated primarily by acupuncture point selection and stimulation frequency in normal rats.

Authors:  Jun-Fan Fang; Jun-Ying Du; Xiao-Mei Shao; Jian-Qiao Fang; Zhe Liu
Journal:  BMC Complement Altern Med       Date:  2017-03-31       Impact factor: 3.659

5.  A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial of Qi-Zhi-Wei-Tong Granules on Postprandial Distress Syndrome-Predominant Functional Dyspepsia.

Authors:  Qing Su; Sheng-Liang Chen; Hua-Hong Wang; Lie-Xin Liang; Ning Dai; Bin Lyu; Jun Zhang; Rong-Quan Wang; Ya-Li Zhang; Yue Yu; Jin-Song Liu; Xiao-Hua Hou
Journal:  Chin Med J (Engl)       Date:  2018-07-05       Impact factor: 2.628

6.  Effects and mechanisms of acupuncture and electroacupuncture for functional dyspepsia: A systematic review.

Authors:  Yu Guo; Wei Wei; Jiande Dz Chen
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

Review 7.  Efficacy Comparison of Different Acupuncture Treatments for Functional Dyspepsia: A Systematic Review with Network Meta-Analysis.

Authors:  Jinhuan Zhang; Yongfeng Liu; Xingxian Huang; Yirong Chen; Liyu Hu; Kai Lan; Haibo Yu
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-18       Impact factor: 2.629

8.  Placebo Response Rates in Acupuncture Therapy Trials for Functional Dyspepsia: A Systematic Review and Meta-Analysis.

Authors:  Jie Liu; Gengqing Song; Yizhou Huang; Chaolan Lv; Ying Wang; Dandan Wu; Chenyu Sun; Meng Jing; Yue Yu
Journal:  J Clin Gastroenterol       Date:  2022-04-01       Impact factor: 3.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.